About this Research Topic
Neglected Global Diseases (NGDs) are infectious diseases and other conditions that cause physical and cognitive impairments, contribute to mother and child illness and death, and make it difficult to earn a living, thereby disproportionately affecting the world’s poorest populations. They include maternal, infant and child health conditions, neglected tropical diseases (NTDs) as well as HIV/AIDS, tuberculosis, and malaria. The World Health Organization (WHO) has a list of 20 NTDs that, combined, cause substantial illness for more than one billion people globally. These diseases thrive in conditions of extreme poverty; areas that generally have unsafe water, poor sanitation, substandard housing, and limited access to health care or essential medicines. In some countries this includes most rural areas, urban slums, or conflict zones, however, it is increasingly recognized that emerging middle-income countries (Brazil, Russia, India, China, and South Africa) contain the highest numbers of people affected.
NGDs impact daily life for many . In countries with weak health and social support systems, they cripple families and contribute to the harsh cycle of poverty. While some NTDs are fatal without treatment, most of them are debilitating and stigmatizing. Children are particularly vulnerable. Overall, NGDs cause great suffering and are a leading cause of chronic disability, diminished quality of life, and premature death. Despite their impact, funding for NTDs research and treatment pales in comparison to “developed-world impacted or supported diseases.”
Unfortunately, particularly in the past 20 years, the development of novel pharmacological targets and new interventions based on these targets to treat NGDs has been limited. However, in recent years there has been a resurgence of research in these areas from low- or middle-income countries (LMICs) researchers themselves. The purpose of this Research Topic, unlike similar Research Topics in this area, is to highlight the novel work of LMIC researchers in developing new targets and interventions to treat NGDs.
We welcome authors particularly from LMICs and institutions, to contribute Original Research and/or Review or Opinion articles that highlight potentially novel pharmacological targets and new therapeutics or interventions to treat NGDs.
--------------------------------------
We kindly advise authors to fully explore the following fee support options Frontiers have in place for article processing charges:
• Frontiers’ Fee support program: Our Fee Support team manages over 2000 applications per month, and in 2020, distributed a budget of $18.5M to support over 14K articles. If you have no other sources of support, you can apply for a discount, and we will do our best to support you as a valued Topic Editor. The criteria for discounts are aligned with the classification of low, mid, and high-income countries provided by the World Bank. You can fill the Fee Support application online here (Preferably, straight after submitting your manuscript).
• Frontiers Institutional Agreements: many international universities have agreements with Frontiers (listed here), where the institution pays all or part of the fees for affiliated researchers. Please check with your Institutional Library if this is applicable to you or your authors. Please note that each Institution determines their own support allocations, without input from Frontiers. Should your institution not participate yet, please ask your library to contact us (or send us an email) via institutions@frontiersin.org to discuss the possibilities.
• Open-access funding sources: Please check whether you are eligible for any financial support options from this list
NGDs impact daily life for many . In countries with weak health and social support systems, they cripple families and contribute to the harsh cycle of poverty. While some NTDs are fatal without treatment, most of them are debilitating and stigmatizing. Children are particularly vulnerable. Overall, NGDs cause great suffering and are a leading cause of chronic disability, diminished quality of life, and premature death. Despite their impact, funding for NTDs research and treatment pales in comparison to “developed-world impacted or supported diseases.”
Unfortunately, particularly in the past 20 years, the development of novel pharmacological targets and new interventions based on these targets to treat NGDs has been limited. However, in recent years there has been a resurgence of research in these areas from low- or middle-income countries (LMICs) researchers themselves. The purpose of this Research Topic, unlike similar Research Topics in this area, is to highlight the novel work of LMIC researchers in developing new targets and interventions to treat NGDs.
We welcome authors particularly from LMICs and institutions, to contribute Original Research and/or Review or Opinion articles that highlight potentially novel pharmacological targets and new therapeutics or interventions to treat NGDs.
--------------------------------------
We kindly advise authors to fully explore the following fee support options Frontiers have in place for article processing charges:
• Frontiers’ Fee support program: Our Fee Support team manages over 2000 applications per month, and in 2020, distributed a budget of $18.5M to support over 14K articles. If you have no other sources of support, you can apply for a discount, and we will do our best to support you as a valued Topic Editor. The criteria for discounts are aligned with the classification of low, mid, and high-income countries provided by the World Bank. You can fill the Fee Support application online here (Preferably, straight after submitting your manuscript).
• Frontiers Institutional Agreements: many international universities have agreements with Frontiers (listed here), where the institution pays all or part of the fees for affiliated researchers. Please check with your Institutional Library if this is applicable to you or your authors. Please note that each Institution determines their own support allocations, without input from Frontiers. Should your institution not participate yet, please ask your library to contact us (or send us an email) via institutions@frontiersin.org to discuss the possibilities.
• Open-access funding sources: Please check whether you are eligible for any financial support options from this list
Keywords: neglected global diseases, low- and middle-income countries, novel pharmacological targets, neglected tropical diseases, HIV/AIDS, Tuberculosis, treatment strategies
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
